Compare RCKT & EVTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | EVTL |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United Kingdom |
| Employees | 202 | 454 |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 338.7M |
| IPO Year | N/A | N/A |
| Metric | RCKT | EVTL |
|---|---|---|
| Price | $3.23 | $2.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $29.73 | $12.70 |
| AVG Volume (30 Days) | 2.4M | ★ 2.7M |
| Earning Date | 05-04-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.40 | $1.90 |
| 52 Week High | $5.45 | $7.60 |
| Indicator | RCKT | EVTL |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 39.41 |
| Support Level | $3.32 | $1.95 |
| Resistance Level | $3.52 | $2.89 |
| Average True Range (ATR) | 0.18 | 0.15 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 96.47 | 18.92 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.